The endocrine and reproductive system: adverse effects of hormonally active substances?
Chemicals that have the intrinsic property to modulate or even disrupt the endocrine system are present in the human environment. Because it is the potency of such chemicals that determines the toxicologic relevance, assessment of the risk to human health must consider both the endocrine disrupting potential and the potency. Usually in vitro assays are applied to detect the potential of a hormone-like effect, and such data are considered useful to set priorities for additional testing and for mechanistic studies. However, such data allow only determination of relative potency of a chemical as compared with other xenobiotics, natural compounds, or endogenous hormones. Relevant information on the endocrine-disrupting potency can be taken only from in vivo assays, eg, the Hershberger (male reproductive organs) and uterotrophic (female reproductive organs) assays, the updated versions of the 28- and 90-day toxicity studies in rodents, and the 2-generation studies in rodents. With the use of this information and the concentration of these chemicals in humans, the potency of the effect as compared with endogenous hormone activity can be estimated. So far, the relative potencies of chemicals tested in in vitro systems as compared with estradiol are several orders of magnitude smaller, whereas potency of the phytoestrogen, eg, isoflavones such as genistein or daidzein, can even exceed that of estradiol, especially in infants who are fed soy-based formula as a sole source of nutrition. Although there are still open questions regarding in utero or early postnatal exposure, the low potencies and concentrations of manmade chemicals as compared with the endogenous hormones in humans make it unlikely that adverse effects occur at common exposure.
Greim
Helmut A
HA
Institute of Toxicology and Environmental Hygiene, Technical University of Munich, Munich, Germany. helmut.greim@lrz.tum.de
D000818:Animals; D001559:Benzhydryl Compounds; D001681:Biological Assay; D004703:Endocrine System / Q000187:drug effects*; D004968:Estrogens, Non-Steroidal / Q000633:toxicity; D005260:Female; D015386:Hazardous Substances / Q000633:toxicity*; D006801:Humans; D066298:In Vitro Techniques; D007529:Isoflavones / Q000502:physiology / Q000633:toxicity*; D008297:Male; D010636:Phenols / Q000633:toxicity; D048789:Phytoestrogens; D028321:Plant Preparations / Q000633:toxicity*; D011247:Pregnancy; D012098:Reproduction / Q000187:drug effects; D018675:Toxicity Tests; D014566:Urogenital System / Q000187:drug effects*; D015262:Xenobiotics / Q000633:toxicity*; D000098826:Bisphenol A Compounds
D001559:Benzhydryl Compounds; D004968:Estrogens, Non-Steroidal; D015386:Hazardous Substances; D007529:Isoflavones; D010636:Phenols; D048789:Phytoestrogens; D028321:Plant Preparations; D015262:Xenobiotics; C025256:nonylphenol; C006780:bisphenol A; D000098826:Bisphenol A Compounds